Genexi accelerates the transition of cutting-edge biotech projects from research to the market. GEN token is qualified as a utility token. The token will be used as a medium of exchange within the ecosystem.

ICO Countries Not Allowed

The following countries are not allowed to participate in the crowdsale:

  • USA

Featured Video

GENEXI Details

Trusted Volume 24H

Trusted Volume calculates volume only from reputable crypto exchanges without fake volumes, all of which are considered to list accurate trading volumes.

NVT Ratio

The Network Value to Transactions (NVT) ratio calculates the dollar value of crypto transaction activity relative to the network value.

Team Location Switzerland

GENEXI Technical Details

Blockchain Ethereum (ERC20)

Pre-ICO Details

Status | Pre-Sale Ended
Pre-ICO Start Date May 15, 2018
Pre-ICO End Date May 31, 2018
Pre-ICO Conversion

1 GEN = 0.01 USD

Pre-ICO Bonus


Project Details

Status | Crowdsale Ended
KYC Required
ICO Start Date Jun 1, 2018
ICO End Date Jul 31, 2018
Soft Cap 20,000,000 USD
Hard Cap 70,000,000 USD
Total Supply 12,000,000,000 GEN
Investor Supply 8.400,000,000 GEN
ICO Conversion

1 GEN = 0.01 USD

Bonus Structure

17% Round 1 01.06 – 14.06
9% Round 2 15.06 – 28.06
5% Round 3 29.06 – 12.07
2% Round 4 13.07 – 31.07

Supply Distribution

70% Public Distribution
10% Long-term Foundation Budget
15% Founders, Team
5% Advisors and Early Contributors
*Unsold tokens will be burned.


 Alexey Zhelyaskov
Alexey Zhelyaskov

Co-Founder, CEO

Aleksei Kirillov
Aleksei Kirillov

Co-Founder, COO

Roman Gilvanov
Roman Gilvanov

Managing Director

Sergey Tiurin
Sergey Tiurin

Head of Medical Research

Andrew Zharkov
Andrew Zharkov

Head of Finance

Alexey Nosikov
Alexey Nosikov

Head of Operations

Andrew Marcus
Andrew Marcus

Head of Strategy

Bogdan Stepanov
Bogdan Stepanov

Head of Business Development

Anton Sklovets
Anton Sklovets

Head of Research

Daria Goriychuk
Daria Goriychuk

Head of HR